Quantcast

Latest Management of cancer Stories

2014-04-23 23:10:18

According to a new Korean study, a new method of diagnosing bladder cancer could “augment or replace” current approaches. Raleigh, NC (PRWEB) April 23, 2014 Cancer researchers in Korea say they have developed a simpler and less invasive way to diagnose bladder cancer from a urine sample. Details of the new study have just been posted on the Cancer Monthly website. Click here to learn more. Scientists with the Natural Product Research Institute at Seoul National University have...

2014-04-23 23:04:55

GIA announces the release of a comprehensive global report on Brachytherapy markets. Global market for Brachytherapy Devices is projected to reach US$411 million by 2020, driven by rising cancer cases, aging population, and growing need for more effective therapeutics. San Jose, California (PRWEB) April 23, 2014 Follow us on LinkedIn - Cancer has emerged as one of the most critical health issues worldwide. Rising incidence of cancer and growing medical awareness continues to increase the...

2014-04-22 08:33:31

Company to Report On Science And Progress Of DCVax-Direct Trial At World's Largest Cancer Conference BETHESDA, Md., April 22, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that ASCO (the American Society for Clinical Oncology) has announced in its Annual Meeting program that the Company will present its DCVax-Direct clinical trial and technology...

2014-04-22 08:33:21

Expanded Reimbursement in Canada and Inclusion in Leading German Physician Guidelines Increase Genomic Health's Impact in Key International Markets REDWOOD CITY, Calif., April 22, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX(®) breast cancer test in major German clinical guidelines. In Canada, the BC Cancer Agency in British Columbia...

Researchers Discover Biomarker Leading To Cancer Drug Resistance
2014-04-21 07:52:12

redOrbit staff & Wire Reports – Your Universe Online Researchers from the University of California, San Diego School of Medicine have located a biomarker that they believe could help explain why many of the medications used to treat lung, breast and pancreatic cancers also promote drug resistance and ultimately cause tumors to form in patients. Writing in the April 20 online edition of Nature Cell Biology, the study authors report the discovery of a molecule known as CD61 that is...

2014-04-20 23:01:14

A federal jury’s decision to award billions of dollars in damages to a bladder cancer patient who took Actos could mean that others in the same situation may also have a right to seek compensation. Raleigh, NC (PRWEB) April 20, 2014 Last week, the Osaka, Japan-based company that produces the diabetes drug Actos and their American marketing partner Eli Lilly were ordered to pay more than $9 billion because Takeda allegedly concealed cancer risks associated with its Actos diabetes drug....

2014-04-16 14:11:59

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy. Wei Chen, professor of physics and co-director of UT Arlington's Center for Security Advances Via Applied Nanotechnology, was testing a copper-cysteamine complex created in his lab when he discovered unexplained decreases in its luminescence, or light emitting power, over a...

2014-04-16 12:29:58

The Canadian Partnership Against Cancer announces $13 million in funding for partner organisations TORONTO, April 16, 2014 /CNW/ - Every person who is living with cancer is unique, and so is that person's cancer journey. The person-centred perspective in cancer care is driven by the needs, values and priorities of the person receiving the care. The Canadian Partnership Against Cancer is pleased to announce $13 million in funding to provinces, territories and cancer organizations...

2014-04-15 23:09:00

The cancer information website Cancer Monthly says bladder cancer patients who took Actos should not wait to seek legal advice, despite drug maker’s plans to appeal a federal jury’s ruling. Raleigh, NC (PRWEB) April 15, 2014 The makers of the diabetes drug Actos say they will appeal last week’s award of $9 billion in punitive damages to a man who claims that Actos caused his bladder cancer, (1) (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No....

2014-04-13 23:01:22

Days after a federal jury announced a $9 billion dollar judgment against the drug’s manufacturers, Cancer Monthly is encouraging bladder cancer patients to know their rights. Raleigh, NC (PRWEB) April 13, 2014 The Japanese manufacturer of the diabetes drug Actos and its partner firm, Eli Lilly & Co., have been ordered to pay $9 billion to Terrence Allen, who was diagnosed with bladder cancer after taking Actos. (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc.,...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'